Prospective evaluation of finger two-point discrimination and carpal tunnel syndrome among women with breast cancer receiving adjuvant aromatase inhibitor therapyBREAST CANCER RESEARCH AND TREATMENTIF32019-05-117OAAI
A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trialBREAST CANCER RESEARCH AND TREATMENTIF32018-05-1113OAAI
Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancerBREAST CANCER RESEARCH AND TREATMENTIF32016-12-0912OAAI
Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor TherapyCLINICAL CANCER RESEARCHIF10.22016-03-1417OA
Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnoverBREAST CANCER RESEARCH AND TREATMENTIF32015-11-0424OA
Association of variants in candidate genes on lipid profiles in women with early breast cancer on adjuvant aromatase inhibitor therapyCANCER RESEARCHIF16.62013-12-150PRE
Aromatase inhibitor-induced modulation of breast density: clinical and genetic effectsBRITISH JOURNAL OF CANCERIF6.82013-10-0126OAAI
CYP2D6 Genotype and Adjuvant Tamoxifen: Meta-Analysis of Heterogeneous Study PopulationsCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52013-09-23143OAAI
Genome-wide discovery of genetic variants affecting tamoxifen sensitivity and their clinical and functional validationANNALS OF ONCOLOGYIF65.42013-07-019OAAI
Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancerBREAST CANCER RESEARCH AND TREATMENTIF32013-04-0255OA
Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer绝经后乳腺癌患者乳腺癌复发风险与心血管疾病发病风险的比较BREAST CANCER RESEARCH AND TREATMENTIF32011-11-0169OA
Plasma Letrozole Concentrations in Postmenopausal Women With Breast Cancer Are Associated With CYP2A6 Genetic Variants, Body Mass Index, and AgeCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52011-10-0596OAAI
Estrogen Receptor Genotypes, Menopausal Status, and the Effects of Tamoxifen on Lipid Levels: Revised and Updated ResultsCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52010-09-0814OAAI
Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case-control studyBRITISH JOURNAL OF CANCERIF6.82010-07-0635OAAI
Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapyBRITISH JOURNAL OF CANCERIF6.82009-12-0112OAAI
Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohortBREAST CANCER RESEARCH AND TREATMENTIF32009-01-2068OA
Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapyBREAST CANCER RESEARCH AND TREATMENTIF32008-12-1236PREAI
Association of polymorphisms of angiogenesis genes with breast cancerBREAST CANCER RESEARCH AND TREATMENTIF32007-09-20107PREAI
The star-allele nomenclature: retooling for translational genomicsCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52007-09-0165PREAI